On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost.
Saved in:
| Title: | On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost. |
|---|---|
| Authors: | Hou LQ; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Liu JR; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Gu JL; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Chen ML; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Kuang LF; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Huang BH; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Zou WY; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Li J; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Jan 17; Vol. 13, pp. 1306367. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2023.1306367 |
